Refining the ammonia hypothesis: A physiology-driven approach to the treatment of hepatic encephalopathy

Mayo Clinic Proceedings

Volumn 90, Issue 5, 2015, Pages 646-658

  Tapper, Elliot B ^a   Jiang, Z Gordon ^a   Patwardhan, Vilas R ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; LACTULOSE; RIFAXIMIN;

ACIDOSIS; AMMONIA BLOOD LEVEL; DIET SUPPLEMENTATION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; HYPOKALEMIA; INTESTINE MUCOSA; INTESTINE TRANSIT TIME; KIDNEY INJURY; KIDNEY METABOLISM; LIVER FUNCTION; MUSCLE ATROPHY; MUSCLE TISSUE; NEUROTOXICITY; NONHUMAN; NUTRITIONAL STATUS; PATHOGENESIS; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; TREATMENT PLANNING; CLINICAL PROTOCOL; COMPLICATION; METABOLISM; PATHOPHYSIOLOGY;

AMMONIA; CLINICAL PROTOCOLS; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA;

EID: 84929030005     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2015.03.003     Document Type: Review

References (125)

1. A.T. Blei, and J. Córdoba Hepatic encephalopathy Am J Gastroenterol 96 7 2001 1968 1976
2. M.L. Volk, R.S. Tocco, J. Bazick, M.O. Rakoski, and A.S. Lok Hospital readmissions among patients with decompensated cirrhosis Am J Gastroenterol 107 2 2012 247 252
3. M.R. Arguedas, T.G. DeLawrence, and B.M. McGuire Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis Dig Dis Sci 48 8 2003 1622 1626
4. J. Cordoba, M. Ventura-Cots, and M. Simón-Talero Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF) J Hepatol 60 2 2014 275 281
5. G.A. Diaz, L.S. Krivitzky, and M. Mokhtarani Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate Hepatology 57 6 2013 2171 2179
6. G.M. Enns, S.A. Berry, G.T. Berry, W.J. Rhead, S.W. Brusilow, and A. Hamosh Survival after treatment with phenylacetate and benzoate for urea-cycle disorders N Engl J Med 356 22 2007 2282 2292
7. J. Fichet, E. Mercier, and O. Genée Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy J Crit Care 24 3 2009 364 370
8. J.P. Ong, A. Aggarwal, and D. Krieger Correlation between ammonia levels and the severity of hepatic encephalopathy Am J Med 114 3 2003 188 193
9. D. Shawcross, Y. Sharifi, and J. Canavan Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis J Hepatol 54 4 2011 640 649
10. J. Stahl Studies of the blood ammonia in liver disease: its diagnostic, prognostic, and therapeutic significance Ann Intern Med 58 1 1963 1 24
11. S.G. Phillip, and B.A. Runyon Serum ammonia level for the evaluation of hepatic encephalopathy JAMA 312 6 2014 643 644
12. J. Albrecht, and M.D. Norenberg Glutamine: a Trojan horse in ammonia neurotoxicity Hepatology 44 4 2006 788 794
13. T. Welbourne, M. Weber, and N. Bank The effect of glutamine administration on urinary ammonium excretion in normal subjects and patients with renal disease J Clin Invest 51 7 1972 1852 1860
14. R.F. Butterworth Complications of cirrhosis III. Hepatic encephalopathy J Hepatol 32 1 suppl 2000 171 180
15. S.W. Olde Damink, R. Jalan, and N.E. Deutz The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis Hepatology 37 6 2003 1277 1285
16. G. Tarantino, V. Citro, and P. Esposito Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins BMC Gastroenterol 9 2009 21
17. K.S. Warren, G. Reboucas, and A.G. Baptista Ammonia metabolism and hepatic coma in hepatosplenic schistosomiasis patients studied before and after portacaval shunt Ann Intern Med 62 6 1965 1113 1133
18. M.D. Leise, J.J. Poterucha, P.S. Kamath, and W.R. Kim Management of hepatic encephalopathy in the hospital Mayo Clin Proc 89 2 2014 241 253
19. R. Butterworth Effects of hyperammonaemia on brain function J Inherit Metab Dis 21 1 1998 6 20
20. M.D. Norenberg Astroglial dysfunction in hepatic encephalopathy Metab Brain Dis 13 4 1998 319 335
21. M.D. Norenberg, and A. Martinez-Hernandez Fine structural localization of glutamine synthetase in astrocytes of rat brain Brain Res 161 2 1979 303 310
22. D. Shawcross, and R. Jalan The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation Cell Mol Life Sci 62 19-20 2005 2295 2304
23. A.R. Jayakumar, K. Rama Rao, A. Schousboe, and M.D. Norenberg Glutamine-induced free radical production in cultured astrocytes Glia 46 3 2004 296 301
24. M.D. Norenberg Astrocyte responses to CNS injury J Neuropathol Exp Neurol 53 3 1994 213 220
25. M. Yudkoff, I. Nissim, and D. Pleasure Astrocyte metabolism of [15N] glutamine: implications for the glutamine-glutamate cycle J Neurochem 51 3 1988 843 850
26. J. Cordoba, J. Gottstein, and A.T. Blei Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema Hepatology 24 4 1996 919 923
27. S. Balata, S.W. Damink, and K. Ferguson Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis Hepatology 37 4 2003 931 939
28. C. Bachmann Mechanisms of hyperammonemia Clin Chem Lab Med 40 7 2002 653 662
29. A.H. Lockwood, J.M. McDonald, and R.E. Reiman The dynamics of ammonia metabolism in man: effects of liver disease and hyperammonemia J Clin Invest 63 3 1979 449
30. V. Felipo, and R.F. Butterworth Neurobiology of ammonia Prog Neurobiol 67 4 2002 259 279
31. M. Llansola, R. Rodrigo, and P. Monfort NMDA receptors in hyperammonemia and hepatic encephalopathy Metab Brain Dis 22 3-4 2007 321 335
32. R. Garcia-Martinez, A. Rovira, and J. Alonso Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume Liver Transpl 17 1 2011 38 46
33. D.L. Shawcross, N.A. Davies, R. Williams, and R. Jalan Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis J Hepatol 40 2 2004 247 254
34. T.H. Tranah, G.K.M. Vijay, J.M. Ryan, and D.L. Shawcross Systemic inflammation and ammonia in hepatic encephalopathy Metab Brain Dis 28 1 2013 1 5
35. D.L. Shawcross, S.S. Shabbir, N.J. Taylor, and R.D. Hughes Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis Hepatology 51 3 2010 1062 1069
36. J.O. Clemmesen, F.S. Larsen, J. Kondrup, B.A. Hansen, and P. Ott Cerebral herniation in patients with acute E liver failure is correlated with arterial ammonia concentration Hepatology 29 3 1999 648 653
37. V. Pichili, K. Rao, A. Jayakumar, and M. Norenberg Inhibition of glutamine transport into mitochondria protects astrocytes from ammonia toxicity Glia 55 8 2007 801 809
38. J. Polson, and W.M. Lee AASLD position paper: the management of acute liver failure Hepatology 41 5 2005 1179 1197
39. T.I. Hassanein, F. Tofteng, and R.S. Brown Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis Hepatology 46 6 2007 1853 1862
40. J. Bajaj, D. Heuman, and P. Hylemon Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis Aliment Pharmacol Ther 39 10 2014 1113 1125
41. J.S. Bajaj, D.M. Heuman, and A.J. Sanyal Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy PloS One 8 4 2013 e60042
42. D.C. Rockey, J.M. Vierling, and P. Mantry Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy Hepatology 59 3 2014 1073 1083
43. N. Assy, B.G. Rosser, G.R. Grahame, and G.Y. Minuk Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis Gastrointest Endosc 49 6 1999 690 694
44. J. Bajaj Review article: the modern management of hepatic encephalopathy Aliment Pharmacol Ther 31 5 2010 537 547
45. W.W. Souba, R.J. Smith, and D.W. Wilmore Glutamine metabolism by the intestinal tract JPEN J Parenter Enteral Nutr 9 5 1985 608 617
46. M. Romero-Gómez, R. Ramos-Guerrero, and L. Grande Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy J Hepatol 41 1 2004 49 54
47. W.V. McDermott Jr., M. Victor, and W.W. Point Exclusion of the colon in the treatment of hepatic encephalopathy N Engl J Med 267 17 1962 850 854
48. J. Walker, A. Emlyn-Williams, A. Craigie, V. Rosenoer, J. Agnew, and S. Sherlock Treatment of chronic portal-systemic encephalopathy by surgical exclusion of the colon Lancet 286 7418 1965 861 866
49. M.M. Díaz-Herrero, J.A. del Campo, and P. Carbonero-Aguilar THDP17 decreases ammonia production through glutaminase Inhibition: a new drug for hepatic encephalopathy therapy PloS One 9 10 2014 e109787
50. J.B. Müller, P. Guggenheim, and U. Haemmerli Treatment of chronic portal-systemic encephalopathy with lactulose Lancet 287 7443 1966 890 893
51. R.S. Rahimi, A.G. Singal, J.A. Cuthbert, and D.C. Rockey Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial JAMA Intern Med 174 11 2014 1727 1733
52. A. Al-Osaimi, B. Quatrara, and I. Melo In-patient hepatic encephalopathy protocol improves in-patient outcome measures: interim analysis Hepatology 50 2009 446A
53. D.H. van Thiel, S. Fagiuoli, H.I. Wright, M.C. Chien, and J.S. Gavaler Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment Hepatology 19 1 1994 67 71
54. E. Wolpert, S. Phillips, and W. Summerskill Transport of urea and ammonia production in the human colon Lancet 298 7739 1971 1387 1390
55. A. Vince, A. Dawson, N. Park, and F. O'Grady Ammonia production by intestinal bacteria Gut 14 3 1973 171 177
56. B. Als-Nielsen, L.L. Gluud, and C. Gluud Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials BMJ 328 7447 2004 1046
57. H. Brown, C. Trey, and W.V. McDermott Lactulose treatment of hepatic encephalopathy in outpatients Arch Surg 102 1 1971 25 27
58. H. Conn, C. Leevy, and Z. Vlahcevic Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double blind controlled trial Gastroenterology 72 4, pt 1 1977 573 583
59. S. Elkington, M. Floch, and H. Conn Lactulose in the treatment of chronic portal-systemic encephalopathy: a double-blind clinical trial N Engl J Med 281 8 1969 408 412
60. D. Heredia, J. Caballeria, V. Arroyo, G. Ravelli, and J. Rodes Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE): a controlled trial J Hepatol 4 3 1987 293 298
61. D. Heredia, J. Teres, N. Orteu, and J. Rodes Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy J Hepatol 7 1 1988 106 110
62. B.C. Sharma, P. Sharma, A. Agrawal, and S.K. Sarin Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo Gastroenterology 137 3 2009 885 891
63. N.M. Bass, K.D. Mullen, and A. Sanyal Rifaximin treatment in hepatic encephalopathy N Engl J Med 362 12 2010 1071 1081
64. B.C. Sharma, P. Sharma, M.K. Lunia, S. Srivastava, R. Goyal, and S. Sarin A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy Am J Gastroenterol 108 9 2013 1458 1463
65. K. Tarao, T. Ikeda, and K. Hayashi Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy Gut 31 6 1990 702 706
66. K.M. Eltawil, M. Laryea, K. Peltekian, and M. Molinari Rifaximin vs conventional oral therapy for hepatic encephalopathy: a meta-analysis World J Gastroenterol 18 8 2012 767 777
67. J.S. Bajaj, K. Saeian, and K.M. Christensen Probiotic yogurt for the treatment of minimal hepatic encephalopathy Am J Gastroenterol 103 7 2008 1707 1715
68. R.G. McGee, A. Bakens, K. Wiley, S.M. Riordan, and A.C. Webster Probiotics for patients with hepatic encephalopathy Cochrane Database Syst Rev 11 2011 CD008716
69. T.M. Bauer, H. Schwacha, and B. Steinbrückner Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia Am J Gastroenterol 97 9 2002 2364 2370
70. D. Shawcross, G. Wright, S.O. Damink, and R. Jalan Role of ammonia and inflammation in minimal hepatic encephalopathy Metab Brain Dis 22 1 2007 125 138
71. S. Shukla, A. Shukla, S. Mehboob, and S. Guha Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy Aliment Pharmacol Ther 33 6 2011 662 671
72. G. Wright, and R. Jalan Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box? Hepatology 46 2 2007 291 294
73. G.W. Neff, M. Jones, and T. Broda Durability of rifaximin response in hepatic encephalopathy J Clin Gastroenterol 46 2 2012 168 171
74. R.K. Dhiman, B. Rana, and S. Agrawal Probiotic VSL# 3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial Gastroenterology 147 6 2014 1327 1337
75. A. O'Brien, and R. Williams Nutrition in end-stage liver disease: principles and practice Gastroenterology 134 6 2008 1729 1740
76. P. Amodio, C. Bemeur, and R. Butterworth The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus Hepatology 58 1 2013 325 336
77. M. Uribe, M.A. Márquez, and G.G. Ramos Treatment of chronic portal: systemic encephalopathy with vegetable and animal protein diets Dig Dis Sci 27 12 1982 1109 1116
78. J. Córdoba, J. López-HellÍn, and M. Planas Normal protein diet for episodic hepatic encephalopathy: results of a randomized study J Hepatol 41 1 2004 38 43
79. M. Plauth, E. Cabre, and O. Riggio ESPEN guidelines on enteral nutrition: liver disease Clin Nutr 25 2 2006 285 294
80. G. Marchesini, G. Bianchi, and M. Merli Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial Gastroenterology 124 7 2003 1792 1801
81. Y. Muto, S. Sato, and A. Watanabe Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis Clin Gastroenterol Hepatol 3 7 2005 705 713
82. B. Als-Nielsen, R.L. Koretz, L. Kjaergard, and C. Gluud Branched-chain amino acids for hepatic encephalopathy Cochrane Database Syst Rev 2 2 2003 CD001939
83. K. De Bruijn, L. Blendis, D. Zilm, P. Carlen, and G. Anderson Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy Gut 24 1 1983 53 60
84. D. Horst, N.D. Grace, and H.O. Conn Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial Hepatology 4 2 1984 279 287
85. I. Les, E. Doval, and R. García-Martínez Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study Am J Gastroenterol 106 6 2011 1081 1088
86. J.C. Bode, P. Hanisch, H. Henning, W. Koenig, F.W. Richter, and C. Bode Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis Hepatology 8 6 1988 1605 1609
87. K. Foeken, and G. De Jong Overt hepatic encephalopathy precipitated by zinc deficiency Gastroenterology 100 1991 1114 1118
88. G. Marchesini, A. Fabbri, G. Bianchi, M. Brizi, and M. Zoli Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis Hepatology 23 5 1996 1084 1092
89. O. Riggio, F. Ariosto, and M. Merli Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy Dig Dis Sci 36 9 1991 1204 1208
90. Y. Takuma, K. Nouso, Y. Makino, M. Hayashi, and H. Takahashi Clinical trial: oral zinc in hepatic encephalopathy Aliment Pharmacol Ther 32 9 2010 1080 1090
91. P. Reding, J. Duchateau, and C. Bataille Oral zinc supplementation improves hepatic encephalopathy: results of a randomised controlled trial Lancet 324 8401 1984 493 495
92. J.M. Henderson, T.D. Boyer, and M.H. Kutner Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial Gastroenterology 130 6 2006 1643 1651
93. W.V. McDermott Jr., and R.D. Adams Episodic stupor associated with an Eck fistula in the human with particular reference to the metabolism of ammonia J Clin Invest 33 1 1954 1 9
94. W.V. McDermott Jr., R.D. Adams, and A.G. Riddell Ammonia metabolism in man Ann Surg 140 4 1954 539 556
95. F. Fanelli, F.M. Salvatori, and P. Rabuffi Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft Am J Roentgenol 193 6 2009 1696 1702
96. O. Riggio, S. Angeloni, and F.M. Salvatori Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts Am J Gastroenterol 103 11 2008 2738 2746
97. P.S. Kamath, R.H. Wiesner, and M. Malinchoc A model to predict survival in patients with end-stage liver disease Hepatology 33 2 2001 464 470
98. T.D. Boyer, and Z.J. Haskal The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009 Hepatology 51 1 2010 306
99. S. Singh, P.S. Kamath, J.C. Andrews, and M.D. Leise Embolization of spontaneous portosystemic shunts for management of severe persistent hepatic encephalopathy Hepatology 59 2 2014 735 736
100. W. Laleman, M. Simon-Talero, and G. Maleux Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy Hepatology 57 6 2013 2448 2457
101. E.E. Owen, J.H. Johnson, and M.P. Tyor The effect of induced hyperammonemia on renal ammonia metabolism J Clin Invest 40 2 1961 215 221
102. C. Dejong, N. Deutz, and P. Soeters Renal ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat J Clin Invest 92 6 1993 2834 2840
103. G. Gabuzda, and P. Hall III Relation of potassium depletion to renal ammonium metabolism and hepatic coma Medicine (Baltimore) 45 6 1966 481 490
104. S.W. Damink, R. Jalan, D.N. Redhead, P.C. Hayes, N.E. Deutz, and P.B. Soeters Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS Hepatology 36 5 2002 1163 1171
105. S.W.O. Damink, C.H. Dejong, and N.E. Deutz Kidney plays a major role in ammonia homeostasis after portasystemic shunting in patients with cirrhosis Am J Physiol-Gastrointest Liver Physiol 291 2 2006 G189 G194
106. J.M. Baertl, S.M. Sancetta, and G.J. Gabuzda Relation of acute potassium depletion to renal ammonium metabolism in patients with cirrhosis J Clin Invest 42 5 1963 696 706
107. S.W. Olde Damink, R. Jalan, and N.E. Deutz Isoleucine infusion during "simulated" upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patients Hepatology 45 3 2007 560 568
108. L. Mpabanzi, S.W.O. Damink, M.C. van de Poll, P.B. Soeters, R. Jalan, and C.H. Dejong To pee or not to pee: ammonia hypothesis of hepatic encephalopathy revisited Eur J Gastroenterol Hepatol 23 6 2011 449 454
109. R.L. Tannen Relationship of renal ammonia production and potassium homeostasis Kidney Int 11 6 1977 453 465
110. K.-H. Han Mechanisms of the effects of acidosis and hypokalemia on renal ammonia metabolism Electrolyte Blood Press 9 2 2011 45 49
111. J.W. Jones, A. Sebastian, H.N. Hulter, M. Schambelan, J.M. Sutton, and E.G. Biglieri Systemic and renal acid-base effects of chronic dietary potassium depletion in humans Kidney Int 21 2 1982 402 410
112. L. Lee Hamm, K.S. Hering-Smith, and N.L. Nakhoul Acid-base and potassium homeostasis Semin Nephrol 33 3 2013 257 264
113. R.L. Tannen The effect of uncomplicated potassium depletion on urine acidification J Clin Invest 49 4 1970 813 827
114. G. Zavagli, G. Ricci, G. Bader, G. Mapelli, F. Tomasi, and B. Maraschin The importance of the highest normokalemia in the treatment of early hepatic encephalopathy Miner Electrolyte Metab 19 6 1992 362 367
115. G.T. Nagami Enhanced ammonia secretion by proximal tubules from mice receiving NH4Cl: role of angiotensin II Am J Physiol-Renal Physiol 282 3 2002 F472 F477
116. R. Jalan, and D. Kapoor Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver Gut 52 7 2003 1041 1045
117. B.M. McGuire, I.A. Zupanets, and M.E. Lowe Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis Hepatology 51 6 2010 2077 2085
118. S. Sushma, S. Dasarathy, R.K. Tandon, S. Jain, S. Gupta, and M.S. Bhist Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial Hepatology 16 1 1992 138 144
119. R. Jalan, G. Wright, N. Davies, and S. Hodges l-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy Med Hypotheses 69 5 2007 1064 1069
120. M. Holecek Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy: therapeutic perspectives Metab Brain Dis 29 1 2014 9 17
121. M. Merli, M. Giusto, and C. Lucidi Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study Metab Brain Dis 28 2 2013 281 284
122. A.J. Montano-Loza, J. Meza-Junco, and C.M. Prado Muscle wasting is associated with mortality in patients with cirrhosis Clin Gastroenterol Hepatol 10 2 2012 166 173
123. M. Holecek, R. Kandar, L. Sispera, and M. Kovarik Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle Amino Acids 40 2 2011 575 584
124. E. Kalaitzakis, R. Olsson, and P. Henfridsson Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis Liver Int 27 9 2007 1194 1201
125. G.W. Neff, M. Jones, and M. Jonas Lack of Clostridium difficile infection in patients treated with rifaximin for hepatic encephalopathy: a retrospective analysis J Clin Gastroenterol 47 2 2013 188 192